Condition: Chronic Coronary Syndrome · Sponsor: Samsung Medical Center
A prospective, multi-center, open-label, randomized controlled, and superiority trial. The trial will compare clinical outcomes between discontinuation of antiplatelet agent and continuation of antiplatelet agent in HBR patients with chronic coronary syndrome treated by DCB angioplasty and standard duration of DAPT, followed by maintenance of single antiplatelet agent without clinical event for at least 1 year from the index procedure.
This description comes directly from the study's public registry record.
Joo Myung Lee, MD, MPH, PhD · 82-2-3410-2575 · drone80@hanmail.net
Seung Hun Lee, MD, PhD · 82-10-6413-7449 · lsh8602@naver.com
Always discuss trial participation with your own doctor first.
| Korea University Ansan Hospital | Ansan, South Korea | Recruiting |
| Keimyung University Dongsan Medical Center | Daegu, South Korea | Recruiting |
| Gangneung Asan Hospital, University of Ulsan College of Medicine | Gangneung, South Korea | Recruiting |
| Ilsan Paik hospital | Goyang, South Korea | Recruiting |
| Chonnam National University Hospital, Chonnam National University Medical School | Gwangju, South Korea | Recruiting |
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong, South Korea | Recruiting |
| Catholic Kwandong University International St. Mary's Hospital | Incheon, South Korea | Recruiting |
| Gachon Cardiovascular Research Institute, Gachon University | Incheon, South Korea | Recruiting |
| Inha University Hospital | Incheon, South Korea | Recruiting |
| Chonbuk National University Hospital and Chonbuk National University Medical School | Jeonju, South Korea | Recruiting |
| Gyeongsang National University Hospital | Jinju, South Korea | Recruiting |
| Chung-Ang University Hospital | Seoul, South Korea | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06742931